[Form 4/A] Omada Health, Inc. Amended Insider Trading Activity

Rhea-AI Filing Summary

Omada Health, Inc. President Shao Wei-Li reported an amended open-market sale of 4,037 shares of Common Stock. The shares were sold on June 12, 2026 at a weighted average price of $17.2407 per share, leaving 316,790 shares beneficially owned afterward.

The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026. This Form 4/A corrects an earlier filing that had overstated the number of shares sold and the President’s resulting share ownership due to an administrative broker error.

Insights

Equity compensation and insider-trading analyst

Routine 10b5-1 sale with small size and corrected figures.

President Shao Wei-Li of Omada Health, Inc. sold 4,037 shares of Common Stock in an open-market transaction at a weighted average price of $17.2407 on June 12, 2026. Following the sale, reported beneficial ownership stands at 316,790 shares.

The filing states the trade was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026, suggesting the timing was scheduled rather than opportunistic. The amendment clarifies that a prior Form 4 overstated shares sold and holdings due to a broker’s administrative error.

The transaction represents a small fraction of the reported post-transaction position, and there are no derivative positions listed in this excerpt. The economic signal is therefore modest, with the key takeaway being accurate disclosure of holdings rather than a major change in insider exposure.

Insider Trade Summary 10b5-1

Net Seller: 4,037 shares ($69,601)

Net Sell 1 txn

Insider Shao Wei-Li

Role President

Sold 4,037 shs ($70K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,037	$17.2407	$70K

Holdings After Transaction: Common Stock — 316,790 shares (Direct, null)

Footnotes (1)

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. This Form 4/A is being filed solely to correct the number of shares reported as sold on June 12, 2026, and the total number of shares beneficially owned. Due to an administrative error by the broker, the original Form 4 filing overstated the number of shares sold under the Reporting Person's 10b5-1 trading plan. This amendment corrects the error to reflect the actual number of shares sold and beneficially owned. This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/24/2026 - 07:26 PM Accepted by SEC EDGAR 06/24/2026 - 07:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shao Wei-Li

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/16/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		S(1)		4,037(2)	D	$17.2407(3)	316,790	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This Form 4/A is being filed solely to correct the number of shares reported as sold on June 12, 2026, and the total number of shares beneficially owned. Due to an administrative error by the broker, the original Form 4 filing overstated the number of shares sold under the Reporting Person's 10b5-1 trading plan. This amendment corrects the error to reflect the actual number of shares sold and beneficially owned.

3. This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Omada Health (OMDA) President Shao Wei-Li report in this Form 4/A?

The filing reports an amended open-market sale of 4,037 shares of Omada Health Common Stock. The sale occurred June 12, 2026, at a weighted average price of $17.2407 per share, leaving the President with 316,790 shares beneficially owned afterward.

Why was this Omada Health (OMDA) Form 4/A filed as an amendment?

The Form 4/A corrects an earlier Form 4 that overstated the number of shares sold and the President’s beneficial ownership. The broker made an administrative error, and this amendment adjusts the reported sale and holdings to reflect the actual figures on June 12, 2026.

How many Omada Health (OMDA) shares did the President sell and at what price?

President Shao Wei-Li sold 4,037 shares of Omada Health Common Stock. The transaction was executed in multiple trades between $17.10 and $17.54 per share, with a reported weighted average sale price of $17.2407 for disclosure purposes in the Form 4/A.

How many Omada Health (OMDA) shares does the President hold after this transaction?

After the corrected sale, the President beneficially owns 316,790 Omada Health shares. This post-transaction balance is disclosed directly in the Form 4/A and replaces the overstated ownership figure previously reported due to the broker’s administrative error.

Was the Omada Health (OMDA) insider trade made under a 10b5-1 trading plan?

Yes. A footnote explains the transaction was made under a Rule 10b5-1 trading plan adopted on March 13, 2026. Such pre-arranged plans schedule trades in advance, indicating the timing of the June 12, 2026 sale was planned rather than discretionary.

What price range did the Omada Health (OMDA) insider sale cover?

The sale was executed in multiple trades at prices ranging from $17.10 to $17.54 per share. The Form 4/A reports a weighted average sale price of $17.2407 and notes that full trade details are available to the SEC, issuer, or shareholders upon request.